- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2019 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study

CITE Title : HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study Personal Author(s) : Heffron, Renee;Stalter, Randy;Pyra, Maria;Nanda, Kavita;Erikson, David W.;Hladik, Florian;Blue, Steven W.;Davis, Nicole L.;Mugo, Nelly;Kourtis, Athena P.;Lingappa, Jairam R.;Baeten, Jared M.; Published Date : March 15 2019 Source : AIDS. 33(4):735-744 URL : https://stacks.cdc.gov/view/cdc/83199 Heffron, Renee et al. (2019). HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study. 33(4). Heffron, Renee et al. "HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study" 33, no. 4 (2019) Heffron, Renee et al. "HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa: a case-control study" vol. 33, no. 4, 2019 Export RIS Citation Information.

:

Heffron, Renee ;

Stalter, Randy

March 15 2019 | AIDS. 33(4):735-744

:

Background:Some observational studies have found increased HIV risk associated with self-reported use of injectable depot medroxyprogesterone acetate ...

To see more results, try removing search filters or changing the search terms